GlassScriptPhysician profile
Hector Heredia-Martinez
NPI 1699882365
$3,716.20
in general payments reported to CMS, 2019-2025
22 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,541 · 2020: $524 · 2021: $289 · 2022: $40.87 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $601.62 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $570.86 | 2019-2020 | |
| Novo Nordisk INC | $487.29 | 2019-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $279.52 | 2019-2020 | |
| Amarin Pharma, INC. | $265.06 | 2019-2020 | |
| Biotronik INC. | $262.74 | 2019-2021 | |
| Lilly USA, LLC | $235.02 | 2019-2020 | |
| Glaxosmithkline, LLC. | $188.02 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.81 | 2019-2020 | |
| Medtronic, INC. | $91.25 | 2021 | |
| Mannkind Corporation | $79.83 | 2019-2020 | |
| Opko Pharmaceuticals, LLC | $75.76 | 2020 | |
| Janssen Pharmaceuticals, INC | $66.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.65 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $49.89 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.51 | 2019-2020 | |
| Mylan Specialty L.P. | $23.68 | 2019 | |
| Abbott Laboratories | $21.16 | 2019 | |
| Becton, Dickinson and Company | $18.05 | 2019 | |
| Allergan, INC. | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Heredia-Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.